CME Credit
Discover how cutting-edge ancillary testing is transforming prostate cancer diagnosis and risk assessment.
Guiding Prostate Cancer Diagnosis with Biomarker Testing
Faculty: Aaron D. Berger, MD, Chief Medical Officer; Director, Clinical Research. Associated Urological Specialists, Solaris Health
This educational activity is directed toward urologists. Primary care physicians, nurse practitioners, physician assistants, and other health care professionals involved in screening and diagnosing patients for prostate cancer are invited to participate as well.
Learning Objectives
In this program, you’ll learn how to:
- Assess cancer risk with greater accuracy
- Guide monitoring and biopsy decisions with more confidence
- Support shared decision-making and patient-centered care
Unlock your CME course
Subscribe for More CME Opportunities
Interested in earning additional CME credits and accessing upcoming educational resources, webinars, and case studies? Subscribe to the IsoPSA email list to receive updates on future programs.